Delcath Systems, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
DCTH Over the counter 3841 http://delcath.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Delcath Systems, Inc.

Delcath Systems Announces $9.5 Million Private Placement - Aug 15th, 2019 4:02 pm
Delcath Enhances Board of Directors With Appointment of Commercial Leader, John R. Sylvester - Jul 29th, 2019 6:00 am
Results of Single Center Study on Delcath’s PHP Therapy Published in Cancer Imaging - Jul 22nd, 2019 6:00 am
Delcath Systems Closes $20 Million Private Placement - Jul 17th, 2019 2:05 pm
Results of Single Center Prospective Study on Delcath’s PHP Therapy Presented at ECIO 2019 - Apr 16th, 2019 6:15 am
Delcath Joins the Ocular Melanoma Community in Recognizing Rare Disease Day - Feb 28th, 2019 8:38 am
Delcath Announces Health Authority Approval for CHEMOSAT in Brazil - Feb 11th, 2019 6:00 am
Delcath Announces Acceptance of Abstract for Oral Presentation at ECIO 2019 - Feb 8th, 2019 6:00 am
Delcath Announces Commercial Licensing Agreement for CHEMOSAT® - Dec 26th, 2018 6:00 am
Delcath Announces 4th Independent Safety Review of Registration Trial Data for Metastatic Ocular Melanoma: Recommended Continuation with no Trial Modification - Dec 18th, 2018 6:00 am
Delcath Announces Third Quarter Fiscal 2018 Financial Results - Nov 13th, 2018 2:52 pm